We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300408:SZSEChaozhou Three-Circle (Group) Co., Ltd. Class A Analysis

Data as of 2026-08-17 - not real-time

CN¥128.17

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Chaozhou Three-Circle (Group) Co.,Ltd. trades at ¥128.17, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 9.6%. Relative strength is 54.9 — neutral — and the MACD signal is bullish. Recent trading has carved out support near ¥86.03 and resistance around ¥137.77.
Multiples put this in overvalued territory: 85.4 times earnings against the sector's 36.5. Analyst price targets sit 22.8% below the current price. Revenue is growing at 46.3% on a 29.2% profit margin. The 0.35% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 104.3%, a beta of 0.76 and a maximum drawdown of 46.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

News zur CHAOZHOU THREE-CIRCLE GROUP AKTIE ✓ und aktueller Realtime-Aktienkurs ✓ CCTC 06951 : NEXT DAY DISCLOSURE...Wall Street Journal1monChaozhou Three-Circle Group Co.Barron's4dChaozhou Three-Circle Group Co.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 78.50
  • MACD momentum is positive
  • 30-day price change of -9.6%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 85.4 versus sector average of 36.5
  • Trading above the 200-day average of 78.50
  • Analyst targets imply -22.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 85.4 versus sector average of 36.5
  • Analyst targets imply -22.8% versus the current price
  • Profit margin of 29.2% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth46.30%
Profit Margin29.19%
P/E Ratio85.4
ROE13.43%
ROA6.78%
Debt/Equity2.53
P/B Ratio11.0
Op. Cash FlowCN¥2.8B
Free Cash FlowCN¥1.5B
Industry P/E36.5

Technical Analysis

TrendNeutral
RSI54.9
SupportCN¥86.03
ResistanceCN¥137.77
MA 20CN¥117.17
MA 50CN¥129.94
MA 200CN¥78.50
MACDBullish
VolumeDecreasing
Fear & Greed Index95.98

Valuation

Fair ValueCN¥29.62
Target PriceCN¥99.00
Upside/Downside-22.76%
GradeOvervalued
TypeGrowth
Dividend Yield0.35%

Risk Assessment

Beta0.76
Volatility104.34%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.